Nitrofurantoin Safety in Polycystic Kidney Disease Patients with UTI
Introduction to Nitrofurantoin Use
- The American College of Physicians recommends nitrofurantoin as first-line therapy for uncomplicated UTIs in polycystic kidney disease patients with a creatinine clearance of ≥30 mL/min 1, 2
- The European Association of Urology suggests that nitrofurantoin should not be used in patients with a creatinine clearance of <30 mL/min due to insufficient efficacy and increased risk of peripheral neuritis 2
Diagnostic Considerations
- The Infectious Diseases Society of America recommends suspecting kidney cyst infection if the patient presents with fever, acute abdominal or flank pain, C-reactive protein ≥50 mg/L, or white blood cell count >11 × 10⁹/L 3, 1, 2
- The American College of Radiology suggests considering an 18F-FDG PET-CT scan for confirmation of kidney cyst infection if needed 3
Treatment Guidelines
- The International Society of Nephrology recommends using nitrofurantoin for 5-7 days in patients with uncomplicated cystitis and a creatinine clearance of ≥30 mL/min 1, 2
- The American Urological Association suggests using trimethoprim-sulfamethoxazole or fluoroquinolones for 4-6 weeks in patients with suspected upper UTI or cyst infection 3, 2
Safety Considerations
- The National Kidney Foundation recommends avoiding nitrofurantoin in patients with a creatinine clearance of <30 mL/min due to increased risk of peripheral neuritis and other adverse effects 2
- The European Medicines Agency suggests monitoring patients for signs of peripheral neuropathy, especially if they have additional risk factors such as renal impairment, anemia, or diabetes mellitus 1, 2